NEW YORK (GenomeWeb News) – Gen-Probe and Affymetrix presented updates on their businesses for investors at the Thomas Weisel Healthcare Conference being held this week in Boston.

Gen-Probe officials said that the firm is on track with clinical trials for its Aptima HPV assay and expects to file for US Food and Drug Administration clearance of the test by the end of 2010. They also said that Panther, Gen-Probe's fully automated molecular instrument, is on schedule for a late 2010 launch in Europe, followed by a US launch in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.